Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency
New England Journal of Medicine · 2024
DOI: 10.1056/nejmc2404977 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von David Rosmarin und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Indiana School of Medicine, Indianapolis, IN. Hauptthemen laut MEDLINE: Autoantibodies, Immunologic Deficiency Syndromes, Interleukin-23, Infections. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Indiana School of Medicine, Indianapolis, IN.
- Icahn School of Medicine at Mount Sinai, New York, NY shivkar.amara@mountsinai.org.
Zitieren
APA
Rosmarin, D., Amara, S., & Lebwohl, M. (2024). Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency. New England Journal of Medicine. https://doi.org/10.1056/nejmc2404977
Vancouver
Rosmarin D, Amara S, Lebwohl M. Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency. New England Journal of Medicine. 2024. doi:10.1056/nejmc2404977
BibTeX
@article{Rosmarin2024,
author = {Rosmarin, David and Amara, Shivkar and Lebwohl, Mark},
title = {Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmc2404977}
}
EUVIMED